Manganese-Enhanced Magnetic Resonance Imaging Detects Declining Pancreatic β-Cell Mass in a Cyclophosphamide-Accelerated Mouse Model of Type 1 Diabetes
Article Information
vol. 62 no. 1 44-48
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 9, 2012
- Accepted July 7, 2012
- Published in print December 20, 2012.
- Published online ahead of print August 29, 2012.
Article Versions
- Previous version (August 29, 2012 - 08:04).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
Author Information
- Patrick F. Antkowiak1,
- Brian K. Stevens2,
- Craig S. Nunemaker3,
- Marcia McDuffie2,3 and
- Frederick H. Epstein1,4⇓
- 1Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia
- 2Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia
- 3Department of Medicine, University of Virginia, Charlottesville, Virginia
- 4Department of Radiology, University of Virginia, Charlottesville, Virginia
- Corresponding author: Frederick H. Epstein, fredepstein{at}virginia.edu
Statistics from Altmetric.com
Article usage
In this Issue
January 2013, 62(1)
Manganese-Enhanced Magnetic Resonance Imaging Detects Declining Pancreatic β-Cell Mass in a Cyclophosphamide-Accelerated Mouse Model of Type 1 Diabetes
